CN108685006A - 一种欧米伽3固体饮料 - Google Patents
一种欧米伽3固体饮料 Download PDFInfo
- Publication number
- CN108685006A CN108685006A CN201810546428.4A CN201810546428A CN108685006A CN 108685006 A CN108685006 A CN 108685006A CN 201810546428 A CN201810546428 A CN 201810546428A CN 108685006 A CN108685006 A CN 108685006A
- Authority
- CN
- China
- Prior art keywords
- parts
- omega
- probiotics
- bamboo
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 16
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 239000006041 probiotic Substances 0.000 claims abstract description 31
- 235000018291 probiotics Nutrition 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 29
- 229930003944 flavone Natural products 0.000 claims abstract description 22
- 235000011949 flavones Nutrition 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 22
- 150000002213 flavones Chemical class 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 239000003094 microcapsule Substances 0.000 claims abstract description 15
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 14
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 13
- 239000000944 linseed oil Substances 0.000 claims abstract description 13
- 229920001202 Inulin Polymers 0.000 claims abstract description 9
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 9
- 229940029339 inulin Drugs 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 6
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 244000082204 Phyllostachys viridis Species 0.000 claims description 6
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 6
- 239000011425 bamboo Substances 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 5
- 244000199866 Lactobacillus casei Species 0.000 claims description 5
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 5
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 5
- 229940017800 lactobacillus casei Drugs 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 244000099147 Ananas comosus Species 0.000 claims description 4
- 235000007119 Ananas comosus Nutrition 0.000 claims description 4
- 240000008067 Cucumis sativus Species 0.000 claims description 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000012265 solid product Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 229940088598 enzyme Drugs 0.000 claims description 3
- 238000010829 isocratic elution Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000000529 probiotic effect Effects 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 2
- 244000189799 Asimina triloba Species 0.000 claims description 2
- 235000006264 Asimina triloba Nutrition 0.000 claims description 2
- 235000000832 Ayote Nutrition 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 235000009467 Carica papaya Nutrition 0.000 claims description 2
- 108010059892 Cellulase Proteins 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 241000219112 Cucumis Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- 240000004244 Cucurbita moschata Species 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 240000001008 Dimocarpus longan Species 0.000 claims description 2
- 235000000235 Euphoria longan Nutrition 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims description 2
- 235000009496 Juglans regia Nutrition 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 244000088415 Raphanus sativus Species 0.000 claims description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 2
- 240000001890 Ribes hudsonianum Species 0.000 claims description 2
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 2
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 241000746966 Zizania Species 0.000 claims description 2
- 235000002636 Zizania aquatica Nutrition 0.000 claims description 2
- 235000004259 Zizania latifolia Nutrition 0.000 claims description 2
- 244000085595 Zizania latifolia Species 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- 230000021736 acetylation Effects 0.000 claims description 2
- 238000006640 acetylation reaction Methods 0.000 claims description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 229940106157 cellulase Drugs 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000013505 freshwater Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 235000015136 pumpkin Nutrition 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000002525 ultrasonication Methods 0.000 claims description 2
- 238000005292 vacuum distillation Methods 0.000 claims description 2
- 235000020234 walnut Nutrition 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 240000000851 Vaccinium corymbosum Species 0.000 claims 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims 1
- 239000003463 adsorbent Substances 0.000 claims 1
- 235000021014 blueberries Nutrition 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000005202 decontamination Methods 0.000 claims 1
- 230000003588 decontaminative effect Effects 0.000 claims 1
- 238000004945 emulsification Methods 0.000 claims 1
- 229940083466 soybean lecithin Drugs 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000000968 intestinal effect Effects 0.000 abstract description 8
- 206010010774 Constipation Diseases 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 230000000840 anti-viral effect Effects 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 235000013406 prebiotics Nutrition 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000007661 gastrointestinal function Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 235000015816 nutrient absorption Nutrition 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract description 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007413 intestinal health Effects 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- -1 Flavone compound Chemical class 0.000 description 2
- 240000008663 Persicaria orientalis Species 0.000 description 2
- 235000018742 Vitex negundo var cannabifolia Nutrition 0.000 description 2
- 244000271612 Vitex negundo var. cannabifolia Species 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 240000004343 Indigofera suffruticosa Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种欧米伽3固体饮料，它采用亚麻籽油微囊粉60‑96重量份、益生菌0.02‑0.1重量份、复合果蔬酵素3‑10重量份、竹叶黄酮3‑20重量份、菊粉1‑10重量份，通过“等量递增法”制成；本发明将益生元和欧米伽3同时包埋成水溶性微囊粉，再将微囊粉同益生菌、复合果蔬酵素、竹叶黄酮优化组和，可改善肠道菌群平衡，增强人体免疫，帮助人体清除血液胆固醇、甘油三酯及人体自由基，在预防及改善心脑血管疾病、糖尿病、癌症等慢病的同时，起到抗病毒抗炎，减轻肠道负担，缓解便秘等胃肠功能虚弱症状的作用，又可促进欧米伽3等营养吸收。
Description
技术领域
本发明涉及食药用菌深加工技术领域，具体涉及一种富含益生菌、酵素及竹叶黄酮的欧米伽3固体饮料。
背景技术
肠道是营养物质吸收的主要场所，营养物质在肠道内的消化吸收是决定营养高效利用的重要因素。人体肠道健康与肠道菌群密不可分。肠道菌群的失调，可造成免疫系统的过度活跃，从而产生自体免疫疾病。益生菌通过调理肠道菌群，维持肠道菌群的平衡，从而促进营养物质的吸收、提高免疫力、预防和治疗便秘及腹泻、降低血脂、抑制肠道病源和腐败微生物的生长，分解致癌物质等。益生元如低聚异麦芽糖、低聚半乳糖、低聚果糖等是益生菌的营养物质，以未经消化的形式进入肠道，通过降低PH值和被有益菌发酵，促进肠道内双歧杆菌、乳酸杆菌等有益菌生长，帮助其调整肠道健康，促进营养物质包括蛋白质、脂肪酸等的吸收。
酵素指具有生物催化功能的高分子物质。存在于所有的动、植物和微生物体内，是维持机体正常功能，消化食物，修复组织等生命活动的一种必需物质，够加快生化反应的速度，人体每天所摄取食物的消化吸收、体内各器官的运作、细胞的新陈代谢都离不开酵素，而分解进去体内任何物质如蛋白质、脂肪、化合物都需要酵素的参与才能够完成。通过增加酵素，可以分解有害菌的温床——宿便，并使之排出体外，清除毒素。同时对于肠胃道功能虚弱或有障碍者，如：胀气、胃痛、腹泻、便秘、口臭等症状，都可使之得到改善。
近年来，病毒性疾病在动物疾病中占主导地位并种类逐年增多，病毒性疾病具有病原变异快和缺乏特异性的治疗药物等特点，相对于细菌性传染病，其更难以诊断和防治。目前FDA批准用于临床的抗病毒药比抗菌药少得多， 而且还存在毒副作用和耐药性等问题。因此，亟需寻找和开发安全、高效的新型抗病毒药物。
黄酮类化合物具有广泛的药理活性，分布广泛，种类繁多，是天然产物中一类重要的化合物。竹叶黄酮是竹叶提取物的主要活性成分之一，在竹叶中的含量占1-2％，主要以荭草普、异荭草普、牡荆普和异牡荆普等黄酮碳普为主，同时，还含有木犀草素、芹菜素等黄酮普元。与氧普黄酮相比，竹叶黄酮结构稳定、不易降解、食用安全性强。因具备较强的自由基清除能力，从而具有良好的消炎、抗病毒、降血脂、抗辐射、抗癌、抗衰老、改善心血管系统和脑神经系统等功能。
欧米伽3，可简称为ω-3，是一组多元不饱和脂肪酸，常见于深海鱼类和某些植物中，对人体健康十分有益。ω-3成份主要有三种：α-亚麻酸（ALA）、二十碳五烯酸（EPA）、二十二碳六烯酸（DHA）。
欧米伽3（ω-3）是生命的核心物质，是心脏、视网膜、大脑等重要组织的的主要脂肪组分。其中来源于植物的α-亚麻酸（α-Linolenic acid, ALA）是ω-3系不饱和脂肪酸家族的“家长”，其在人体肝脏内、在去饱和酶和延长酶的作用下，能够转化成为人体必需的生命活性因子EPA（二十碳五烯酸，俗称血管清道夫）和DHA（二十二碳六烯酸，俗称脑黄金）。DHA和EPA是脑、视网膜等细胞膜的重要成分，都选择性的渗入大脑皮质、视网膜、睾丸、精子等重要器官中，参与构成乙醇胺磷脂和神经磷脂，同时对提高大脑细胞功能、提高记忆力、预防老年痴呆症、预防心脑血管疾病、癌症、糖尿病等具有显著效果。可以说其对维持人体进化、保持身体健康具有重要作用，但其自身不能合成，必需在食物中摄取。
虽然欧米伽3（ω-3）对人体具有多项重要生理功能，但随着现代人类食物结构的改变，欧米伽3不饱和脂肪酸摄入越来越少。据中国居民的膳食结构的调查结果发现，中国人均欧米伽3摄入量40mg/d，与其他国家相比都相去甚远，甚至不到世界卫生组织和联合国粮农组推荐摄入量的一半，导致人体欧米伽3（ω-3）严重缺乏，破坏人体脂肪酸组成平衡，导致许多“富贵病“如糖尿病、高血压和高血脂的产生，所以必须通过日常饮食来补充。同时，2013版《中国居民膳食营养素参考摄入量》中建议，国人α-亚麻酸每天的摄入量应为1600-1800毫克。
目前，市面上的欧米伽3脂肪酸补充食品主要以深海鱼油、植物性油脂如亚麻籽油、紫苏籽油及其软胶囊为主，其所含欧米伽3脂肪酸为脂溶性，一般具有容易氧化、酸败、不易吸收等缺点，同时也不具备调理肠道健康的功能，对于促消化、缓解便秘胀气、抗病抗炎的功能并不显著。
发明内容
本发明的目的在于针对现有技术的缺陷和不足，提供一种具有调节肠道健康作用的含有益生菌的富含益生菌、酵素及竹叶黄酮的欧米伽3固体饮料。
为实现上述目的，本发明采用的技术方案是：它由如下重量份的组分配比而成：亚麻籽油微囊粉60-96份、益生菌0.02-0.1份、复合果蔬酵素3-10份、竹叶黄酮3-20份、菊粉1-10份；
进一步地，所述的亚麻籽油微囊粉通过以下方法制备：将38份亚麻籽油、0.02份大豆卵磷脂、2份乙酰化单、双甘油脂肪酸酯在60℃条件下混溶并保温制得油相，将28份低聚异麦芽糖粉、24份低聚果糖、6份酪蛋白酸钠、0.1份磷酸氢二钾和70份水在60℃下混溶后保温制得水相，随后将油相加入到水相中，用高速剪切机乳化15-30min后，再以28-30KHz、功率1000-1200W的超声波处理15-30min，将上述得到的乳液在喷雾干燥塔中干燥，保持乳化液温度为65℃，喷雾干燥的进风温度为170℃、出风温度80℃，将乳化液经喷雾干燥后筛分、冷却，制得颗粒；
进一步地，所述的益生菌为嗜酸乳杆菌、乳双岐杆菌、CBT混合益生菌中2种或2种以上组成的菌种；
进一步地，所述的嗜酸乳杆菌、乳双歧杆菌、CBT混合益生菌在定量益生菌粉中的活菌数分别为：嗜酸乳杆菌为3.0×109-3.6×1012cfu/g，乳双歧杆菌为7.0×109-8.5×1012cfu/g，CBT混合益生菌为1.0×109-2.0×1012cfu/g；
进一步地，所述的CBT混合益生菌由下列重量份的组分配比而成：长双歧杆菌4-8份、干酪乳杆菌2-4份、鼠李糖乳杆菌4-8份；
进一步地，所述的CBT混合益生菌中长双歧杆菌、干酪乳杆菌、鼠李糖乳杆菌在定量益生菌粉中的活菌数分别为：长双歧杆菌1.0×109-3.0×1012cfu/g、干酪乳杆菌1.0×109-3.0×1012cfu/g、鼠李糖乳杆菌1.0×109-3.0×1012cfu/g；
进一步地，所述的复合果蔬酵素通过以下方法制备：取木瓜9份、菠萝7份、凤梨9份、蓝莓5份、黑加仑8份、哈密瓜15份、核桃5份、黑木耳10份、香蕉25份、葡萄10份、苹果15份、柠檬10份、桂圆7份、芒果10份、萝卜20份、蘑菇15份、黄瓜15份、南瓜19份、茭白11份、西红柿10份、青瓜14份，并用清水洗净切块，晾干；然后按照1:15（g/ml）比例加入蒸馏水，煮沸1.5小时；再加入50份红糖、30份蜂蜜并搅拌均匀，再离心取上清液；调节所得上清液PH至5.0后投入发酵桶，接入发酵液体积3%的酿酒酵母与乳酸菌，在32℃发酵30天以上，然后过滤、喷雾干燥得果蔬酵素粉；
进一步地，所述的竹叶黄酮通过以下方法制备：将新鲜的淡水竹竹叶在40℃下烘干后粉碎成10目左右大小，然后加入重量比为0.05：0.05的纤维素酶、果胶酶的复合酶解液，在40℃条件下酶解20h，过滤后得酶解液；然后用质量百分比浓度为20-30％的乙醇溶液将所得酶解液于大孔吸附树脂层析柱中等度洗脱除去杂质，得第一洗脱液；再以质量百分比浓度为40-70％的乙醇溶液将所得酶解液于大孔吸附树脂层析柱中等度洗脱，得第二洗脱液；再将第二洗脱液采用减压蒸馏的方法分离出乙醇和固体产物，蒸馏温度为90℃，固体产物烘干至恒重得竹叶黄酮。
进一步地，一种欧米伽3固体饮料的制备工艺为：先将益生菌与亚麻籽油微囊粉按等量递增法混合均匀，再加复合果蔬酵素按等量递增法混合均匀，再加竹叶黄酮按等量递增法混合均匀，最后加菊粉按等量递增法混合均匀。
采用上述方案后，本发明有益效果为：本发明所述的一种欧米伽3固体饮料，将益生元和欧米伽3同时包埋成水溶性微囊粉，再将微囊粉同益生菌、复合果蔬酵素、竹叶黄酮优化组和，人们同时摄入欧米伽3、益生菌、复合果蔬酵素、竹叶黄酮和益菌因子的益生元，可大量增殖有益菌，提高外源性益生菌在肠道粘膜的定植率，改善肠道菌群平衡，增强人体免疫，帮助人体清除血液胆固醇、甘油三酯及人体自由基，在预防及改善心脑血管疾病、糖尿病、癌症等慢病的同时，起到抗病毒抗炎，减轻肠道负担，缓解便秘等胃肠功能虚弱症状的作用，又可促进欧米伽3等营养吸收。
具体实施方式
下面对本发明作进一步的说明。
实施例1：取亚麻籽油微囊粉79.95份、含嗜酸乳杆菌、乳双歧杆菌的益生菌0.05份、复合果蔬酵素5份、竹叶黄酮10份、菊粉5份；采用“等量递增法”，先将益生菌与亚麻籽油微囊粉按等量递增法混合均匀，再加复合果蔬酵素按等量递增法混合均匀，再加竹叶黄酮按等量递增法混合均匀，最后加菊粉按等量递增法混合均匀。
实施例2：取亚麻籽油微囊粉64.9份、含嗜酸乳杆菌、乳双歧杆菌、CBT混合益生菌的益生菌0.1份、复合果蔬酵素10份、竹叶黄酮15份、菊粉10份；采用“等量递增法”，先将益生菌与亚麻籽油微囊粉按等量递增法混合均匀，再加复合果蔬酵素按等量递增法混合均匀，再加竹叶黄酮按等量递增法混合均匀，最后加菊粉按等量递增法混合均匀。
以上所述，仅用以说明本发明的技术方案而非限制，本领域普通技术人员对本发明的技术方案所做的其它修改或者等同替换，只要不脱离本发明技术方案的精神和范围，均应涵盖在本发明的权利要求范围当中。
Claims (9)
1.一种欧米伽3固体饮料，其特征在于它由如下重量份的组分配比而成：亚麻籽油微囊粉60-96份、益生菌0.02-0.1份、复合果蔬酵素3-10份、竹叶黄酮3-20份、菊粉1-10份。
2.根据权利要求1所述的一种欧米伽3固体饮料，其特征在于所述的亚麻籽油微囊粉通过以下方法制备：将38份亚麻籽油、0.02份大豆卵磷脂、2份乙酰化单、双甘油脂肪酸酯在60℃条件下混溶并保温制得油相，将28份低聚异麦芽糖粉、24份低聚果糖、6份酪蛋白酸钠、0.1份磷酸氢二钾和70份水在60℃下混溶后保温制得水相，随后将油相加入到水相中，用高速剪切机乳化15-30min后，再以28-30KHz、功率1000-1200W的超声波处理15-30min，将上述得到的乳液在喷雾干燥塔中干燥，保持乳化液温度为65℃，喷雾干燥的进风温度为170℃、出风温度80℃，将乳化液经喷雾干燥后筛分、冷却，制得颗粒。
3.根据权利要求1所述的一种欧米伽3固体饮料，其特征在于所述的益生菌为嗜酸乳杆菌、乳双岐杆菌、CBT混合益生菌中2种或2种以上组成的菌种。
4.根据权利要求3所述的一种欧米伽3固体饮料，其特征在于所述的嗜酸乳杆菌、乳双歧杆菌、CBT混合益生菌在定量益生菌粉中的活菌数分别为：嗜酸乳杆菌为3.0×109-3.6×1012cfu/g，乳双歧杆菌为7.0×109-8.5×1012cfu/g，CBT混合益生菌为1.0×109-2.0×1012cfu/g。
5.根据权利要求3所述的一种欧米伽3固体饮料，其特征在于所述的CBT混合益生菌由下列重量份的组分配比而成：长双歧杆菌4-8份、干酪乳杆菌2-4份、鼠李糖乳杆菌4-8份。
6.根据权利要求5所述的一种欧米伽3固体饮料，其特征在于所述的CBT混合益生菌中长双歧杆菌、干酪乳杆菌、鼠李糖乳杆菌在定量益生菌粉中的活菌数分别为：长双歧杆菌1.0×109-3.0×1012cfu/g、干酪乳杆菌1.0×109-3.0×1012cfu/g、鼠李糖乳杆菌1.0×109-3.0×1012cfu/g。
7.根据权利要求1所述的一种欧米伽3固体饮料，其特征在于所述的复合果蔬酵素通过以下方法制备：取木瓜9份、菠萝7份、凤梨9份、蓝莓5份、黑加仑8份、哈密瓜15份、核桃5份、黑木耳10份、香蕉25份、葡萄10份、苹果15份、柠檬10份、桂圆7份、芒果10份、萝卜20份、蘑菇15份、黄瓜15份、南瓜19份、茭白11份、西红柿10份、青瓜14份，并用清水洗净切块，晾干；然后按照1:15（g/ml）比例加入蒸馏水，煮沸1.5小时；再加入50份红糖、30份蜂蜜并搅拌均匀，再离心取上清液；调节所得上清液PH至5.0后投入发酵桶，接入发酵液体积3%的酿酒酵母与乳酸菌，在32℃发酵30天以上，然后过滤、喷雾干燥得果蔬酵素粉。
8.根据权利要求1所述的一种欧米伽3固体饮料，其特征在于所述的竹叶黄酮通过以下方法制备：将新鲜的淡水竹竹叶在40℃下烘干后粉碎成10目左右大小，然后加入重量比为0.05：0.05的纤维素酶、果胶酶的复合酶解液，在40℃条件下酶解20h，过滤后得酶解液；然后用质量百分比浓度为20-30％的乙醇溶液将所得酶解液于大孔吸附树脂层析柱中等度洗脱除去杂质，得第一洗脱液；再以质量百分比浓度为40-70％的乙醇溶液将所得酶解液于大孔吸附树脂层析柱中等度洗脱，得第二洗脱液；再将第二洗脱液采用减压蒸馏的方法分离出乙醇和固体产物，蒸馏温度为90℃，固体产物烘干至恒重得竹叶黄酮。
9.一种欧米伽3固体饮料的制备工艺，其特征在于它的工艺方法为：先将益生菌与亚麻籽油微囊粉按等量递增法混合均匀，再加复合果蔬酵素按等量递增法混合均匀，再加竹叶黄酮按等量递增法混合均匀，最后加菊粉按等量递增法混合均匀。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810546428.4A CN108685006A (zh) | 2018-05-31 | 2018-05-31 | 一种欧米伽3固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810546428.4A CN108685006A (zh) | 2018-05-31 | 2018-05-31 | 一种欧米伽3固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108685006A true CN108685006A (zh) | 2018-10-23 |
Family
ID=63848783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810546428.4A Pending CN108685006A (zh) | 2018-05-31 | 2018-05-31 | 一种欧米伽3固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108685006A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111567661A (zh) * | 2020-06-02 | 2020-08-25 | 姚礼群 | 一种复合凝胶糖果及其制备方法 |
| CN112617206A (zh) * | 2020-12-18 | 2021-04-09 | 北京本草兰科技有限公司 | 一种降低炎性细胞因子及调节免疫功能的复合益生菌及其应用 |
| CN114451555A (zh) * | 2021-12-31 | 2022-05-10 | 湖州维义生物科技股份有限公司 | 一种富含植物欧米伽3、植物蛋白、木酚素的水溶功能食品及制备方法 |
| CN115669842A (zh) * | 2022-11-07 | 2023-02-03 | 中科京川(四川)生物科技有限公司 | 不饱和脂肪酸-神经酸复配固体饮料及其制备方法 |
| CN115736020A (zh) * | 2022-12-02 | 2023-03-07 | 张家界茅岩莓有限公司 | 一种莓茶固体饮料及其制备方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101973984A (zh) * | 2010-10-13 | 2011-02-16 | 南方医科大学 | 一种提取竹叶总黄酮的方法 |
| CN104542974A (zh) * | 2015-01-29 | 2015-04-29 | 王维义 | 一种欧米伽-3酸奶粉及其制备工艺 |
| CN106173773A (zh) * | 2016-07-06 | 2016-12-07 | 慧谷生命科技湖北有限公司 | 一种酵素益生菌固体饮料及其制备方法 |
| CN106721854A (zh) * | 2017-02-05 | 2017-05-31 | 河南康元生物科技股份有限公司 | 一种亚麻籽固体饮料的制备方法 |
| CN107969579A (zh) * | 2016-10-24 | 2018-05-01 | 张艳 | 一种复合花果酵素饮品的制备方法 |
| CN109430663A (zh) * | 2018-12-26 | 2019-03-08 | 张颖 | 固体饮料 |
-
2018
- 2018-05-31 CN CN201810546428.4A patent/CN108685006A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101973984A (zh) * | 2010-10-13 | 2011-02-16 | 南方医科大学 | 一种提取竹叶总黄酮的方法 |
| CN104542974A (zh) * | 2015-01-29 | 2015-04-29 | 王维义 | 一种欧米伽-3酸奶粉及其制备工艺 |
| CN106173773A (zh) * | 2016-07-06 | 2016-12-07 | 慧谷生命科技湖北有限公司 | 一种酵素益生菌固体饮料及其制备方法 |
| CN107969579A (zh) * | 2016-10-24 | 2018-05-01 | 张艳 | 一种复合花果酵素饮品的制备方法 |
| CN106721854A (zh) * | 2017-02-05 | 2017-05-31 | 河南康元生物科技股份有限公司 | 一种亚麻籽固体饮料的制备方法 |
| CN109430663A (zh) * | 2018-12-26 | 2019-03-08 | 张颖 | 固体饮料 |
Non-Patent Citations (1)
| Title |
|---|
| 郝利平等: "《食品添加剂》", 31 July 2016, 北京：中国农业大学出版社 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111567661A (zh) * | 2020-06-02 | 2020-08-25 | 姚礼群 | 一种复合凝胶糖果及其制备方法 |
| CN112617206A (zh) * | 2020-12-18 | 2021-04-09 | 北京本草兰科技有限公司 | 一种降低炎性细胞因子及调节免疫功能的复合益生菌及其应用 |
| CN114451555A (zh) * | 2021-12-31 | 2022-05-10 | 湖州维义生物科技股份有限公司 | 一种富含植物欧米伽3、植物蛋白、木酚素的水溶功能食品及制备方法 |
| CN115669842A (zh) * | 2022-11-07 | 2023-02-03 | 中科京川(四川)生物科技有限公司 | 不饱和脂肪酸-神经酸复配固体饮料及其制备方法 |
| CN115669842B (zh) * | 2022-11-07 | 2023-12-01 | 中科京川(四川)生物科技有限公司 | 不饱和脂肪酸-神经酸复配固体饮料及其制备方法 |
| CN115736020A (zh) * | 2022-12-02 | 2023-03-07 | 张家界茅岩莓有限公司 | 一种莓茶固体饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103027231B (zh) | 一种复合益生菌发酵中草药活性保健液及其制备方法 | |
| CN108685006A (zh) | 一种欧米伽3固体饮料 | |
| CN106135977B (zh) | 一种具有补钙明目功能的钙果粉的生产方法 | |
| CN105995976A (zh) | 一种具有降脂减肥作用的综合酵素粉及其应用 | |
| US20090181437A1 (en) | Method for producing a conjugated linoleic acid glyceride | |
| CN106798252B (zh) | 一种具有调理肠胃降血脂溶血栓功效的纳豆产品 | |
| CN107125736A (zh) | 一种覆盆子酵素的制备方法 | |
| CN104982928B (zh) | 一种红豆杉果保健酵素及其制备方法 | |
| CN102318806B (zh) | 一种益生菌发酵南瓜、胡萝卜蔬菜粉的制备方法 | |
| CN103271274B (zh) | 一种营养保健粥 | |
| CN112535218A (zh) | 促进智力发育和肠道健康的母乳化婴幼儿配方奶粉及其制备方法和应用 | |
| CN107568736A (zh) | 解酒醒酒医学配方食品 | |
| CN112244299A (zh) | 一种具有缓解非酒精性脂肪肝功能的益生菌组合物及其制备方法 | |
| CN102742653B (zh) | 一种健脑安神益生菌羊奶片及其制备方法 | |
| CN111329055B (zh) | 一种簕菜酵素的制备方法 | |
| CN106858577A (zh) | 制备具有保肝护肝、调节脂肪肝代谢功能的植物酵素的发酵组合物及制法 | |
| CN113499401A (zh) | 一种治疗阿尔茨海默病的药物组合物及其制备方法和应用 | |
| CN106974262A (zh) | 肠道益生杆菌在治疗和预防肥胖及其相关疾病中的应用 | |
| CN108159291A (zh) | 植物提取物与益生菌复配制品及其制备方法 | |
| CN102047960B (zh) | 一种木槿花酸奶及其制作方法 | |
| CN106213096A (zh) | 一种发酵香蕉制备酵素饮料的方法 | |
| CN116671569A (zh) | 一种活性益生菌抗氧化软糖及其制备方法 | |
| CN102754695A (zh) | 一种牛蒡益生菌羊奶片及其制备方法 | |
| CN115053929B (zh) | 一种适合脂肪肝人群的配方奶粉及其制备 | |
| CN102742654B (zh) | 一种养颜美容益生菌羊奶片及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181023 |
|
| WD01 | Invention patent application deemed withdrawn after publication |